Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region.

Kim MN, Kim BK, Han KH.

J Gastroenterol. 2013 Jun;48(6):681-8. doi: 10.1007/s00535-013-0770-9. Epub 2013 Mar 6. Review.

2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.

Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.

PMID:
20492323
4.

Hepatocellular carcinoma in the Asia pacific region.

Yuen MF, Hou JL, Chutaputti A; Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2009 Mar;24(3):346-53. doi: 10.1111/j.1440-1746.2009.05784.x. Epub 2009 Feb 12. Review.

PMID:
19220670
5.

Current status of hepatitis C virus infection in Korea.

Suh DJ, Jeong SH.

Intervirology. 2006;49(1-2):70-5. Review.

PMID:
16166792
6.

Hepatitis B and C virus-related carcinogenesis.

Fung J, Lai CL, Yuen MF.

Clin Microbiol Infect. 2009 Nov;15(11):964-70. doi: 10.1111/j.1469-0691.2009.03035.x. Review.

7.

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

Ann Intern Med. 2007 May 1;146(9):649-56.

PMID:
17470833
8.

The epidemiology and prevention of hepatocellular carcinoma.

Monto A, Wright TL.

Semin Oncol. 2001 Oct;28(5):441-9. Review.

PMID:
11685737
9.

[Hepatocellular carcinoma, hepatitis B virus and the immune system].

Grob PJ.

Schweiz Med Wochenschr. 1986 Aug 23;116(34):1133-45. Review. German.

PMID:
3020684
11.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
12.

[Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].

Schott E, Bergk A, Berg T.

Z Gastroenterol. 2008 Jan;46(1):69-80. doi: 10.1055/s-2007-963684. Review. German.

PMID:
18188819
13.

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.

Omata M, Yoshida H, Shiratori Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. Review.

PMID:
16234063
14.

Hepatocellular carcinoma: an update.

Dominguez-Malagón H, Gaytan-Graham S.

Ultrastruct Pathol. 2001 Nov-Dec;25(6):497-516. Review.

PMID:
11783914
15.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
16.

Natural history of chronic hepatitis B and C.

Imperial JC.

J Gastroenterol Hepatol. 1999 May;14 Suppl:S1-5. Review.

PMID:
10382630
17.

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

Chen DS.

Princess Takamatsu Symp. 1995;25:27-32. Review.

PMID:
8875606
18.

Prevention of hepatocellular carcinoma complicating chronic hepatitis C.

Ueno Y, Sollano JD, Farrell GC.

J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x. Review.

PMID:
19368633
19.

The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.

Marotta F, Vangieri B, Cecere A, Gattoni A.

Clin Ter. 2004 May;155(5):187-99. Review.

PMID:
15344567
20.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903

Supplemental Content

Support Center